The Latest Breaking News from Prostate Cancer

Hall of Fame second baseman Ryne Sandberg announces return of prostate cancer, spreading to other organs. Baseball community shows support.

Sandberg announced his metastatic prostate cancer diagnosis in January 2024

A breakthrough study has identified the genetic risk factors that contribute to increased prostate cancer in African men. The study, the largest of its kind, recruited 7,500 men from eastern, southern and west Africa. The study is especially important because African men have a high risk of prostate cancer.

BNT324/DB-1311 trial data show significant antitumor activity in various cancers, with high response rates in small cell lung and prostate cancer patients.

Janux Therapeutics reports updated clinical data for JANX007, highlighting significant efficacy, safety, and durability in advanced prostate cancer patients.

Every so often there is an urgent call for a national prostate cancer screening programme to be introduced, usually following the diagnosis of a high-profile person with the disease.

Positive high-level results from the CAPItello-281 Phase III trial showed that AstraZeneca's Truqap (capivasertib) in combination with abiraterone and androgen deprivation therapy (ADT) demonstrated a statistically

Nearly one in two men in Scotland will be affected by prostate disease at some point in their lives, according to Prostate Scotland.

White button mushroom or Agaricus bisporus, one of the most popular edible fungus in the world, can shrink cancer tumours, delaying their growth, as per new clinical trials on the use of food as medicine. Not only it slows tumour growth, but also increases the efficiency of cancer-fighting immune cells.

ORIC Pharmaceuticals is a stock analyst price targets currently signal double-bagger potential in. See what the excitement around this firm is all about.

A ‘Man Van’ mobile testing unit was sent to target at-risk groups in London, working with local hospitals and community leaders to drive awareness.